Argenx is urging patients to “Live Vyvidly.” The biotech put the message out in a direct-to-consumer TV ad that paints Vyvgart Hytrulo as a drug that can help people with chronic inflammatory ...
Biogen (BIIB) and Stoke Therapeutics (STOK) announced a collaboration for the development and commercialization of zorevunersen, a potential ...
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback